These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 29317239

  • 1. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion 56Fe radiation induced brain injury in mice.
    Gan L, Wang Z, Si J, Zhou R, Sun C, Liu Y, Ye Y, Zhang Y, Liu Z, Zhang H.
    Toxicol Appl Pharmacol; 2018 Feb 15; 341():1-7. PubMed ID: 29317239
    [Abstract] [Full Text] [Related]

  • 2. Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain.
    Wani WY, Gudup S, Sunkaria A, Bal A, Singh PP, Kandimalla RJ, Sharma DR, Gill KD.
    Neuropharmacology; 2011 Dec 15; 61(8):1193-201. PubMed ID: 21784090
    [Abstract] [Full Text] [Related]

  • 3. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
    Mercer JR, Yu E, Figg N, Cheng KK, Prime TA, Griffin JL, Masoodi M, Vidal-Puig A, Murphy MP, Bennett MR.
    Free Radic Biol Med; 2012 Mar 01; 52(5):841-9. PubMed ID: 22210379
    [Abstract] [Full Text] [Related]

  • 4. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α.
    Xi Y, Feng D, Tao K, Wang R, Shi Y, Qin H, Murphy MP, Yang Q, Zhao G.
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep 01; 1864(9 Pt B):2859-2870. PubMed ID: 29842922
    [Abstract] [Full Text] [Related]

  • 5. Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ.
    Dare AJ, Bolton EA, Pettigrew GJ, Bradley JA, Saeb-Parsy K, Murphy MP.
    Redox Biol; 2015 Aug 01; 5():163-168. PubMed ID: 25965144
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective Efficacy of Mitochondrial Antioxidant MitoQ in Suppressing Peroxynitrite-Mediated Mitochondrial Dysfunction Inflicted by Lead Toxicity in the Rat Brain.
    Maiti AK, Saha NC, More SS, Panigrahi AK, Paul G.
    Neurotox Res; 2017 Apr 01; 31(3):358-372. PubMed ID: 28050775
    [Abstract] [Full Text] [Related]

  • 7. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
    Dashdorj A, Jyothi KR, Lim S, Jo A, Nguyen MN, Ha J, Yoon KS, Kim HJ, Park JH, Murphy MP, Kim SS.
    BMC Med; 2013 Aug 06; 11():178. PubMed ID: 23915129
    [Abstract] [Full Text] [Related]

  • 8. MitoQ--a mitochondria-targeted antioxidant.
    Tauskela JS.
    IDrugs; 2007 Jun 06; 10(6):399-412. PubMed ID: 17642004
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model.
    Dare AJ, Logan A, Prime TA, Rogatti S, Goddard M, Bolton EM, Bradley JA, Pettigrew GJ, Murphy MP, Saeb-Parsy K.
    J Heart Lung Transplant; 2015 Nov 06; 34(11):1471-80. PubMed ID: 26140808
    [Abstract] [Full Text] [Related]

  • 11. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.
    Ng LF, Gruber J, Cheah IK, Goo CK, Cheong WF, Shui G, Sit KP, Wenk MR, Halliwell B.
    Free Radic Biol Med; 2014 Jun 06; 71():390-401. PubMed ID: 24637264
    [Abstract] [Full Text] [Related]

  • 12. Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?
    Lu C, Zhang D, Whiteman M, Armstrong JS.
    Antioxid Redox Signal; 2008 Mar 06; 10(3):651-60. PubMed ID: 17999633
    [Abstract] [Full Text] [Related]

  • 13. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.
    Gioscia-Ryan RA, LaRocca TJ, Sindler AL, Zigler MC, Murphy MP, Seals DR.
    J Physiol; 2014 Jun 15; 592(12):2549-61. PubMed ID: 24665093
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ.
    Stucki DM, Ruegsegger C, Steiner S, Radecke J, Murphy MP, Zuber B, Saxena S.
    Free Radic Biol Med; 2016 Aug 15; 97():427-440. PubMed ID: 27394174
    [Abstract] [Full Text] [Related]

  • 15. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.
    Young ML, Franklin JL.
    Mol Cell Neurosci; 2019 Dec 15; 101():103409. PubMed ID: 31521745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by Idh2 deficiency.
    Kim YR, Baek JI, Kim SH, Kim MA, Lee B, Ryu N, Kim KH, Choi DG, Kim HM, Murphy MP, Macpherson G, Choo YS, Bok J, Lee KY, Park JW, Kim UK.
    Redox Biol; 2019 Jan 15; 20():544-555. PubMed ID: 30508699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.